Orbem provides AI-powered imaging and analytics solutions to deliver non-invasive biological insights.
Orbem has raised $64.6M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
Orbem's investors include General Catalyst, Supernova Invest, Innovation Industries, 83North, European Innovation Council.
Orbem is headquartered in Munich, Germany.
Orbem provides AI-powered imaging and analytics solutions to deliver non-invasive biological insights.
Orbem is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orbem — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/orbem-munich-2. Accessed October 21, 2026.
VCBacked. (2026). Orbem — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/orbem-munich-2
{{cite web |title=Orbem — Funding & Investors |url=https://www.vcbacked.co/company/orbem-munich-2 |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated